Lilly Exploring Strategic Alternatives for Animal Health Biz Post author:Sam Post published:January 31, 2018 Post category:BioPharma Sluggish growth is the main driver for the decision.. Source: BioSpace You Might Also Like 22nd Century Group, Inc. Now Free Of Restrictive License Agreement With September 24, 2017 La Jolla Pharma Announces Financial Results For The Three And Six Months Ended June 30, 2017 And Recent Corporate Progress July 27, 2017 Bioverativ To Report Second Quarter 2017 Financial Results On August 2, 2017 July 6, 2017
La Jolla Pharma Announces Financial Results For The Three And Six Months Ended June 30, 2017 And Recent Corporate Progress July 27, 2017
